FBRX Stock Summary and Trading Ideas (Forte Biosciences | NASDAQ:FBRX)

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Forte Biosciences trades on the NASDAQ stock market under the symbol FBRX.

As of August 14, 2026, FBRX stock price declined to $76.83 with 487,898 million shares trading.

FBRX has a beta of 0.48, meaning it tends to be less sensitive to market movements. FBRX has a correlation of 0.00 to the broad based SPY ETF.

FBRX has a market cap of $1.63 billion. This is considered a Small Cap stock.

In the last 3 years, FBRX traded as high as $77.20 and as low as $4.11.

The top ETF exchange traded funds that FBRX belongs to (by Net Assets): IWM, IWO, VTI, IWC, VXF.

FBRX has outperformed the market in the last year with a return of +610.1%, while the SPY ETF gained +21.5%. In the last 3 month period, FBRX beat the market returning +220.7%, while SPY returned +4.0%. However, in the most recent 2 weeks FBRX has underperformed the stock market by returning +0.3%, while SPY returned +3.9%.

FBRX support price is $72.30 and resistance is $81.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBRX shares will trade within this expected range on the day.